These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38852673)

  • 1. Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis.
    van den Berg RB; Ganesh M; Crul M; Wilms EB; Swart EL; Westerman EM
    J Pharm Sci; 2024 Jun; ():. PubMed ID: 38852673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding unconscious injection of vial-derived rubber particles during intra-articular drug administration.
    Hecker A; Di Maro A; Liechti EF; Klenke FM
    Osteoarthr Cartil Open; 2021 Jun; 3(2):100164. PubMed ID: 36474986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
    Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
    PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on particle contamination produced by syringe needles and rubber stoppers for pharmaceutical solutions].
    Zhao L; Wang HS; Han ZF
    Zhonghua Hu Li Za Zhi; 1997 Jan; 32(1):12-4. PubMed ID: 9304949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations.
    Jambon A; Forat M; Marchand C; Morel C; Merienne C; Filali S; Pirot F
    Eur J Hosp Pharm; 2024 May; ():. PubMed ID: 38789246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing of parenteral drug products for visible particles: comparison of the Ph. Eur. method with an alternative method using polarised light.
    Borgonje PE; Dunnewind T; Bosma L; Tokromo-Evegaars M; Meulenhoff PCW; Breukels O
    Eur J Hosp Pharm; 2023 Mar; ():. PubMed ID: 36894297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate contamination from siliconized rubber stoppers--a statistical evaluation.
    Li LC; Parasrampuria J; Tian Y
    J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlaboratory comparison about feasibility of insoluble particulate matter test for injections with reduced test volume in light obscuration method.
    Harazono A; Shibata H; Kiyoshi M; Muto T; Fukuda J; Torisu T; Saitoh S; Nishimura H; Uchiyama S; Ishii-Watabe A
    Biologicals; 2019 Jan; 57():46-49. PubMed ID: 30553568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of glass particle contamination according to method of ampule cutting and needle aspiration].
    Park JS; Oh HR; Seo BH; Bhang JH
    Taehan Kanho Hakhoe Chi; 2006 Oct; 36(6):1033-41. PubMed ID: 17091003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visible Particulate Contamination Control for Injectable Products: A Life-Cycle Approach.
    Langille SE
    PDA J Pharm Sci Technol; 2020; 74(3):359-366. PubMed ID: 31732691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glass contamination in parenterally administered medication.
    Preston ST; Hegadoren K
    J Adv Nurs; 2004 Nov; 48(3):266-70. PubMed ID: 15488040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative profile of the use of filter needles in Quebec and France in healthcare facility].
    Painchart L; Odou P; Bussières JF
    Ann Pharm Fr; 2018 Jan; 76(1):71-77. PubMed ID: 29145996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Discrepancy between the European Pharmacopoeia Test and an Adopted United States Pharmacopoeia Test Regarding the Weight Uniformity of Scored Tablet Halves: Is Harmonization Required?
    Zaid AN; Ghoush AA; Al-Ramahi R; Are'r M
    PDA J Pharm Sci Technol; 2012; 66(1):20-7. PubMed ID: 22307659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Particulate contamination associated with the manipulation of drugs in glass ampules: A literature review].
    Painchart L; Odou P; Bussières JF
    Ann Pharm Fr; 2018 Jan; 76(1):3-15. PubMed ID: 28800916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-sealing capacity of vial stoppers after multiple needle punctures.
    Ponto JA
    J Am Pharm Assoc (2003); 2013; 53(1):58-60. PubMed ID: 23636157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral handling precaution: particulate introduction resulting from needle sheath contamination.
    Baumgartner TG; Schmidt GL; Sitren HS; Cerda JJ
    Hosp Pharm; 1986 Apr; 21(4):323-6. PubMed ID: 10276290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.